Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Cronos Group (NASDAQ:CRON) through any online brokerage.
Other companies in Cronos Group’s space includes: Theravance Biopharma Inc (NASDAQ:TBPH), Atai Beckley NV (NASDAQ:ATAI), Xeris Biopharma Holdings Inc (NASDAQ:XERS), Phibro Animal Health Corp (NASDAQ:PAHC) and Rapport Therapeutics Inc (NASDAQ:RAPP).
Cronos Group has a consensus price target of $3.00.
The stock price for Cronos Group (NASDAQ: CRON) is $3.1 last updated December 15, 2025 at 7:59 PM EST.
There are no upcoming dividends for Cronos Group.
Cronos Group does not have any upcoming earnings scheduled.
There is no upcoming split for Cronos Group.
Cronos Group is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.